Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib sodium pretreatment for prevention of etomidate-induced myoclonus
ChiCTR-IPR-15007296Phase 4Recruiting
- Sponsor
- Mianyang Central Hospital
- Start
- Nov 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of parecoxib and etomidate in etomidate-induced myoclonus (EIM) (2 arms), sponsored by Mianyang Central Hospital. Primary endpoint: Incidence of myoclonus. Started Nov 2015; status: recruiting.
02
Drugs
parecoxibetomidate
03
Conditions
etomidate-induced myoclonus (EIM)
Beyond the preview
Go deeper on ChiCTR-IPR-15007296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007296.